Drug details
Emsam (selegiline transdermal system)
type of Antiparkinson Agents, MAO Type B Inhibitors
Emsam (selegiline transdermal system) is an antidepressant used to treat major depressive disorder in adults.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- vomiting,
- fever,
- confusion,
- chest pain,
- vision problems,
- pounding in your neck or ears,
- sudden numbness,
- diarrhea
- sweating,
- weakness,
- agitation,
- restlessness,
- shivering,
- mood changes,
- vomiting, and
- anxiety,
- panic attacks,
- trouble sleeping,
- impulsive behavior,
- irritableness,
- hostility,
- aggression,
- increased depression,
- thoughts of self-harm,
- hallucinations,
- twitching,
- fast or slow heartbeats,
- fast heart rate,
- loss of coordination,
- muscle stiffness,
- neck stiffness,
- severe dizziness,
- racing thoughts,
- unusual risk-taking behavior,
- increased energy,
- talkativeness,
- dilated pupils,
- extreme happiness,
- hyperactivity (mental or physical),
- sudden and severe headache,
- problems with speech or balance,
The following drugs are related to Emsam, either as a replacement or used together:
- Trintellix (vortioxetine tablets)